Roughly 2.2 million new cancer cases worldwide could be traced back to these two very common infections, a new study found.
AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) today announced positive topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed treatment duration epcoritamab, a T-cell engaging ...
Part of Bristol Myers Squibb's Global Patient Week, the initiative reflects a shared commitment to patient care in ...
A ketogenic diet increased small-intestinal tumors in cancer-prone mice while reducing tumors in the colon, revealing a ...
In 1983, a teenager with a modem and a list of phone numbers talked his way into a Defense Department computer, asked it to play a game, and ...
Saros Therapeutics, a company in Rosalind Franklin University of Medicine and Science's (RFU) Helix 51 biomedical incubator, has received its second National Cancer Institute (NCI) Phase II award of ...
Boost ROI through partnership-led European entry, prioritizing scalable oral small molecules, biomarker-defined patients, and high-demand breast cancer and NSCLC indications.Dublin, Oct. 02, 2026 ...
Misinformation about cancer can affect health decisions. Get the facts behind common myths about cancer risk, screening, ...
Fall is here, and so is Baton Rouge General’s one-day pink pumpkin patch. Today, find pastel gourds covering the hospital’s ...
The ceremony celebrated not only marks, medals and trophies, but also children who refused to surrender to adversity, ...
Children in San Antonio are learning about nutrition, exercise and other healthy habits through a free eight-week program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results